Aleva Neurotherapeutics SA
This article was originally published in Start Up
Executive Summary
The electrode leads used for deep brain stimulation to treat such conditions as Parkinson’s disease, depression and essential tremors have become a lot smarter, thanks to technology developed by Switzerland’s Aleva Neurotherapeutics SA. The company’s microDBS platform is an evolution of micro-electro-mechanical systems that allows for precise stimulation of targeted brain tissue, leaving the adjacent region unaffected.